[HTML][HTML] Development of vaccines for Plasmodium vivax malaria
Plasmodium vivax continues to cause significant morbidity outside Africa with more than
50% of malaria cases in many parts of South and South-east Asia, Pacific islands, Central …
50% of malaria cases in many parts of South and South-east Asia, Pacific islands, Central …
[PDF][PDF] Development of vaccines for Plasmodium vivax malaria
I Mueller, AR Shakri, CE Chitnis - 2015 - researchgate.net
abstract Plasmodium vivax continues to cause significant morbidity outside Africa with more
than 50% of malaria cases in many parts of South and South-east Asia, Pacific islands …
than 50% of malaria cases in many parts of South and South-east Asia, Pacific islands …
[PDF][PDF] Development of vaccines for Plasmodium vivax malaria
I Mueller, AR Shakri, CE Chitnis - 2015 - cyberleninka.org
abstract Plasmodium vivax continues to cause significant morbidity outside Africa with more
than 50% of malaria cases in many parts of South and South-east Asia, Pacific islands …
than 50% of malaria cases in many parts of South and South-east Asia, Pacific islands …
[引用][C] Development of vaccines for Plasmodium vivax malaria
I Mueller, AR Shakri, CE Chitnis - Vaccine, 2015 - cir.nii.ac.jp
Development of vaccines for Plasmodium vivax malaria.
I Mueller, AR Shakri, CE Chitnis - Vaccine, 2015 - europepmc.org
Plasmodium vivax continues to cause significant morbidity outside Africa with more than
50% of malaria cases in many parts of South and South-east Asia, Pacific islands, Central …
50% of malaria cases in many parts of South and South-east Asia, Pacific islands, Central …
Development of vaccines for Plasmodium vivax malaria
I Mueller, AR Shakri, CE Chitnis - Vaccine, 2015 - infona.pl
Plasmodium vivax continues to cause significant morbidity outside Africa with more than
50% of malaria cases in many parts of South and South-east Asia, Pacific islands, Central …
50% of malaria cases in many parts of South and South-east Asia, Pacific islands, Central …
Development of vaccines for Plasmodium vivax malaria
I Mueller, AR Shakri, CE Chitnis - Vaccine, 2015 - pubmed.ncbi.nlm.nih.gov
Plasmodium vivax continues to cause significant morbidity outside Africa with more than
50% of malaria cases in many parts of South and South-east Asia, Pacific islands, Central …
50% of malaria cases in many parts of South and South-east Asia, Pacific islands, Central …
Development of vaccines for Plasmodium vivax malaria.
I Mueller, AR Shakri, CE Chitnis - 2015 - cabidigitallibrary.org
Plasmodium vivax continues to cause significant morbidity outside Africa with more than
50% of malaria cases in many parts of South and South-east Asia, Pacific islands, Central …
50% of malaria cases in many parts of South and South-east Asia, Pacific islands, Central …
[PDF][PDF] Development of vaccines for Plasmodium vivax malaria
I Mueller, AR Shakri, CE Chitnis - Vaccine, 2015 - core.ac.uk
abstract Plasmodium vivax continues to cause significant morbidity outside Africa with more
than 50% of malaria cases in many parts of South and South-east Asia, Pacific islands …
than 50% of malaria cases in many parts of South and South-east Asia, Pacific islands …
[PDF][PDF] Development of vaccines for Plasmodium vivax malaria
I Mueller, AR Shakri, CE Chitnis - Vaccine, 2015 - openaccessrepository.it
abstract Plasmodium vivax continues to cause significant morbidity outside Africa with more
than 50% of malaria cases in many parts of South and South-east Asia, Pacific islands …
than 50% of malaria cases in many parts of South and South-east Asia, Pacific islands …